THE USE OF BROMOCRIPTINE FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER IN TWO CHEMICALLY DEPENDENT PATIENTS

Documents similaires

• DIAGNOSING ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND LEARNING DISABILITIES WITH CHEMICALLY DEPENDENT ADOLESCENTS
  par: RALPH, N.
• RECOGNIZING AND TREATING ATTENTION DEFICIT DISORDERS IN CHEMICALLY DEPENDENT ADOLESCENTES
  par: LOOFF, D.H
• BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
  par: BARRICKMAN, L.L
• BROMOCRIPTINE AS INITIAL THERAPY IN ELDERLY PARKINSONIAN PATIENTS
• COMPARISON OF CLONIDINE RESPONSE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER WITH AND WITHOUT COMORBID TIC DISORDERS
  par: STEINGARD, R.